CARDIOSÍNTESIS PODCAST

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans.

1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial

2. The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials

3. Effect Of Anti-fibrotic Therapy On Regression Of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) In Aortic Stenosis Patients With High Fibrotic Burden: The Reduce-MFA DZHK 25-trial

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans.

1. SirPAD: Sirolimus-Coated vs. Uncoated Balloons in Angioplasty For Infrainguinal Artery Disease

2. Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI

3. Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention In Unprotected Left Main Coronary Artery Disease - The Optimal Trial

4. Artificial Intelligence Based Screening For Structural Heart Disease Using An ECG: Results From The PREVUE-VALVE Study
5. Digoxin in Rheumatic Heart Disease: A Multi-Center, Randomized, Double Blind, Placebo-controlled Trial

6. Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans.
1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial
2. Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial
3. Protect The Head To Head Trial: Randomized Comparison of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement
4. Two-Year Outcomes After Transcatheter Tricuspid Repair Without Cross-over in the Randomized Tri-fr Trial
5. Spironolactone in the Treatment of Heart Failure (SPIRIT-HF)

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans.
1. Efficacy And Safety Of Sotatercept In Combined Post- And Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From The Phase 2 Cadence Trial
2. Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3)
3. A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina- ORBITA-CTO Trial
4. Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM Trial

En este episodio de Cardiosíntesis, exploramos los ensayos clínicos y guías más importantes de este primer día en el Congreso Americano de Cardiología 2026. Los temas abarcados fueron:

-Ischemia: Does It Still Matter? Debating Its Role in Real-World IH

-Ultrasound-Facilitated catheter director Thrombolysis vs anticoagulation alone for acute intermediate - high risk pulmonary embolism:
HI- PEITHO

-Dash patterned groceries to reduce blood pressure Among Adults with treated hypertension: GoFRESHRx